Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 12, 2009

View Archived Issues

Imatinib prevents, reverses diabetes in nonobese mice

Lower doses of PfCP2.9 malaria vaccine candidate tested in phase I study

Device captures metastatic cells from circulation and delivers apoptotic signal

MenACWY-TT meningococcal vaccine immunogenic in adolescents

FDA approves Prism's NDA for Nexterone in ventricular fibrillation and tachycardia

Clinical Data presents results from Vilazodone and Stedivaze trials

Fasgen and Centocor sign research and license agreement in oncology

Synta and Roche enter agreement for small-molecule drugs targeting CRACM channels

Novel anti-EGFR family member antibodies described in recent patent

Xenon discloses new sodium channel blockers with analgesic properties

Astellas claims new N-type calcium channel blockers for alleviating pain

Novartis imparts novel chemokine CXCR2 receptor antagonists in recent patent

Recent Argenta Discovery patent discloses new HNE inhibitors for respiratory disorders

Quark doses first patient in phase I/II QPI-1002 trial for delayed graft function

Aegera initiates phase II AEG-35156 trial in non-small cell lung cancer

Michael J. Fox Foundation awards grant to Arcadia for development of ERbeta agonists in PD

FDA grants approval to Ark to initiate patient recruitment into phase III trial of Trinam

BioMimetic completes enrollment into clinical trial of Augment Bone Graft

Sinclair and Graceway sign U.S. agreement for Atopiclair for atopic dermatitis

FDA extends PDUFA action date for Ipsen's Reloxin BLA for glabellar lines

PAION's sedative CNS-7056 meets target profile in proof-of-concept study

Juvaris presents positive data from JVRS-100 adjuvanted flu vaccine trial

RegeneRx reports phase II RGN-137 results in chronic pressure ulcers

SCY-635 demonstrates proof-of-concept in HCV-infected adults

Sucampo completes enrollment in cobiprostone trial for NSAID-induced ulcers

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 8, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...